Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Prepaid Assets (2019 - 2026)

ADC Therapeutics has reported Prepaid Assets over the past 8 years, most recently at $4.3 million for Q1 2026.

  • Quarterly results put Prepaid Assets at $4.3 million for Q1 2026, down 40.6% from a year ago — trailing twelve months through Mar 2026 was $4.3 million (down 40.6% YoY), and the annual figure for FY2025 was $6.1 million, down 35.62%.
  • Prepaid Assets reached $4.3 million in Q1 2026 per ADCT's latest filing, down from $6.1 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $27.2 million in Q1 2023 and bottomed at $4.3 million in Q1 2026.
  • Median Prepaid Assets over the past 5 years was $12.2 million (2022), compared with a mean of $13.4 million.
  • The largest annual shift saw Prepaid Assets surged 81.09% in 2023 before it crashed 70.36% in 2025.
  • Over 5 years, Prepaid Assets stood at $8.2 million in 2022, then rose by 25.75% to $10.3 million in 2023, then fell by 8.64% to $9.4 million in 2024, then tumbled by 35.62% to $6.1 million in 2025, then decreased by 29.9% to $4.3 million in 2026.
  • Business Quant data shows Prepaid Assets for ADCT at $4.3 million in Q1 2026, $6.1 million in Q4 2025, and $5.5 million in Q3 2025.